One of 30 sites for the NIH Division of Allergy, Immunology, and Transplantation (DAIT)/NIAID Systemic Allergic Reactions to SARS-CoV-2 Vaccination Clinical Study. Study’s goal is to Assess the number of participants with allergic reactions to either the Pfizer BioNtech or the Moderna COVID-19 Vaccine in the High-Allergy/Mast Cell Disorder (HA/MCD) population.
Creation of a Pediatric to Adult Rheumatology Clinic (PARC), a clinic focused on transition of adults with pediatric onset rheumatic diseases. Creation of a full service inpatient rheumatology consultation service at Baylor St Luke’s Medical Center – Texas Medical Center Hospital
Innovative clinical outcomes research program in systemic lupus erythematosus at the Baylor Medicine at the McNair Campus and Harris Health System
Featured in 35 journal article publications in the past academic year 2021. Research funding in fiscal year 2020 to 2021 of $3.25 million awarded through National Institutes of Health; Department of Veteran Affairs and national research organizations
Section is home to the Biology of Inflammation Center which is dedicated to the support of translational immunology research at Baylor through a faculty that includes investigators from diverse fields with broad research interests within the field of immunology
Two outstanding, independent clinical fellowship training programs in rheumatology and allergy/clinical immunology
Our patients receive individualized, cutting edge care for autoimmune diseases using diagnostic tools to diagnose and treat their diseases, while emphasizing compassion through our team of nurses, doctors and trainees.